Skip to main content
IP Group PLC logo

IP Group PLC — Investor Relations & Filings

Ticker · IPO ISIN · GB00B128J450 LEI · 213800HG22UM138WFG43 IL Financial and insurance activities
Open in API
Filings indexed 1,205 across all filing types
Latest filing 2024-04-02 Regulatory Filings
Country GB United Kingdom
Listing IL IPO

About IP Group PLC

https://www.ipgroupplc.com/

IP Group PLC is an intellectual property commercialization firm that specializes in creating, building, and supporting early-stage, science-based businesses. The company provides capital, expertise, and strategic guidance to innovators, helping to transform groundbreaking research into tangible impact. Its investment portfolio is focused on three core sectors: life sciences, aimed at curing and preventing disease; deeptech, focused on developing disruptive technologies for digital resilience and new capabilities; and cleantech, which supports scalable solutions to address climate change. By partnering with scientists and entrepreneurs, IP Group works to develop defensible innovations with the potential to address significant global challenges, aiming to deliver both strong financial returns and positive societal impact.

Recent filings

Filing Released Lang Actions
Total Voting Rights
Regulatory Filings Classification · 1% confidence The document is a 'Voting Rights and Capital' disclosure, which is a standard regulatory requirement under the Disclosure and Transparency Rules (DTR 5.6.1) for UK-listed companies. It provides the total number of shares and voting rights at month-end. While it relates to capital, it is a recurring regulatory notification rather than a specific corporate action like a share issue or buyback, and it is distributed via the RNS (Regulatory News Service). Given the specific nature of this disclosure, it falls under the 'Regulatory Filings' category.
2024-04-02 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document is titled 'Transaction in Own Shares' and explicitly details the purchase of ordinary shares by IP Group plc on behalf of itself, pursuant to a share buyback programme announced on December 18, 2023. It provides aggregate data and individual transaction details regarding the repurchase of shares. This activity directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase/issuance), which maps to the filing code POS.
2024-04-02 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document explicitly states the subject as 'Transaction in Own Shares' and details the purchase of ordinary shares by the company (IP Group plc) pursuant to a share buyback programme. It provides specific transaction dates, volumes, prices, and the resulting treasury share count. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The presence of the RNS Number and the closing statement referencing RNS and the London Stock Exchange confirms it is a regulatory announcement, but the specific content dictates the POS classification over the general RNS fallback.
2024-03-28 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document is titled 'Transaction in Own Shares' and details the purchase of ordinary shares by IP Group plc on the London Stock Exchange as part of a share buyback programme announced on December 18, 2023. It provides specific details on the date, number of shares purchased, prices paid, and the resulting treasury share balance. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). Although it is distributed via RNS, the specific content mandates the POS classification over the general RNS fallback.
2024-03-26 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document explicitly states the subject as 'Transaction in Own Shares' and details the purchase of ordinary shares by the company (IP Group plc) pursuant to a previously announced 'share buyback programme'. It provides specific transaction dates, volumes, prices, and the resulting number of shares held in treasury. This directly matches the definition for 'Transaction in Own Shares' (Code: POS). The presence of the RNS number and LSE context confirms it is a regulatory disclosure, but POS is the most specific category available.
2024-03-25 English
Director Declaration
Board/Management Information Classification · 1% confidence The document is a short announcement released via RNS (Regulatory News Service) on March 25, 2024. The core content is the disclosure that a Non-Executive Director, Dr. Elaine Sullivan, has been appointed to the board of another company (Zealand Pharma A/S). This type of disclosure, specifically concerning director appointments/changes and referencing Listing Rules (LR 9.6.14R), directly matches the definition of Board/Management Information (MANG). Although it is distributed via RNS, the specific subject matter is director change, making MANG the most precise classification over the general RNS fallback.
2024-03-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.